Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease

BACKGROUND AND PURPOSE: MTI has the potential to detect abnormalities in normal-appearing white and gray matter on conventional MR imaging. Early detection methods and disease progression markers are needed in HD research. Therefore, we investigated MTI parameters and their clinical correlates in premanifest and manifest HD. MATERIALS AND METHODS: From the Leiden TRACK-HD study, 78 participants (28 controls, 25 PMGC, 25 MHD) were included. Brain segmentation of cortical gray matter, white matter, caudate nucleus, putamen, pallidum, thalamus, amygdala, and hippocampus was performed using FSL's automated tools FAST and FIRST. Individual MTR values were calculated from these regions and MTR histograms constructed. Regression analysis of MTR measures from all gene carriers with clinical measures was performed. RESULTS: MTR peak height was reduced in both cortical gray (P = .01) and white matter (P = .006) in manifest HD compared with controls. Mean MTR was also reduced in cortical gray matter (P = .01) and showed a trend in white matter (P = .052). Deep gray matter structures showed a uniform pattern of reduced MTR values (P < .05). No differences between premanifest gene carriers and controls were found. MTR values correlated with disease burden and motor and cognitive impairment. CONCLUSIONS: Throughout the brain, disturbances in MTI parameters are apparent in early HD and are homogeneous across white and gray matter. The correlation of MTI with clinical measures indicates the potential to act as a disease monitor in clinical trials. However, our study does not provide evidence for MTI as a marker in premanifest HD.

[1]  S J Tabrizi,et al.  Magnetization Transfer Imaging in Premanifest and Manifest Huntington Disease: A 2-Year Follow-Up , 2013, American Journal of Neuroradiology.

[2]  Chris Frost,et al.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data , 2012, The Lancet Neurology.

[3]  Jeroen van der Grond,et al.  Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease , 2012, Human brain mapping.

[4]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[5]  Chris Frost,et al.  Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis , 2011, The Lancet Neurology.

[6]  S J Tabrizi,et al.  Tapping linked to function and structure in premanifest and symptomatic Huntington disease , 2010, Neurology.

[7]  M. Battaglini,et al.  Magnetization Transfer MR Imaging Demonstrates Degeneration of the Subcortical and Cortical Gray Matter in Huntington Disease , 2010, American Journal of Neuroradiology.

[8]  R. Reilmann,et al.  Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[9]  Jeroen van der Grond,et al.  Early atrophy of pallidum and accumbens nucleus in Huntington’s disease , 2010, Journal of Neurology.

[10]  F Barkhof,et al.  Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study , 2010, Multiple sclerosis.

[11]  H. Shill,et al.  Olfaction in the Elderly: A Cross-Sectional Analysis Comparing Parkinson's Disease with Controls and Other Disorders , 2010, The International journal of neuroscience.

[12]  Jeroen van der Grond,et al.  Magnetization transfer imaging in ‘premanifest’ Huntington’s disease , 2009, Journal of Neurology.

[13]  Nick C Fox,et al.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.

[14]  R. A. C. Hughes,et al.  Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis , 2009, Journal of Neurology.

[15]  Jane S. Paulsen,et al.  Diffusion Tensor Imaging in Preclinical Huntington’s Disease , 2009, Brain Imaging and Behavior.

[16]  Jane S. Paulsen,et al.  Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[17]  Nick C Fox,et al.  Quantitative magnetization transfer imaging in Alzheimer disease. , 2007, Radiology.

[18]  Jane S. Paulsen,et al.  fMRI detection of early neural dysfunction in preclinical Huntington's disease , 2007, Journal of the International Neuropsychological Society.

[19]  A. MacKay,et al.  Magnetic resonance imaging of myelin , 2007, Neurotherapeutics.

[20]  Massimo Filippi,et al.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve , 2007, Neurotherapeutics.

[21]  G. Comi,et al.  A longitudinal conventional and magnetization transfer magnetic resonance imaging study of optic neuritis , 2007, Multiple sclerosis.

[22]  Z Khaleeli,et al.  Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  M. van Buchem,et al.  Detection of change in CNS involvement in neuropsychiatric SLE: A magnetization transfer study , 2006, Journal of magnetic resonance imaging : JMRI.

[24]  David S Tuch,et al.  Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.

[25]  Nick C Fox,et al.  Increased rate of whole-brain atrophy over 6 months in early Huntington disease , 2006, Neurology.

[26]  Jane S. Paulsen,et al.  Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.

[27]  B Fischl,et al.  Regional cortical thinning in preclinical Huntington disease and its relationship to cognition , 2005, Neurology.

[28]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[29]  Jane S. Paulsen,et al.  fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. , 2004, AJNR. American journal of neuroradiology.

[30]  Mario Mascalchi,et al.  Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.

[31]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[32]  Wilhelm Gaus,et al.  Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.

[33]  Mircea Ariel Schoenfeld,et al.  Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging , 2004, NeuroImage.

[34]  Massimo Filippi,et al.  The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis , 2003, The Lancet Neurology.

[35]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[36]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[37]  Yulin Ge,et al.  Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. , 2002, AJNR. American journal of neuroradiology.

[38]  J K Udupa,et al.  Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[39]  G. Comi,et al.  Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.

[40]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[41]  J. Grace,et al.  Assessing Frontal Lobe Behavioral Syndromes with the Frontal Lobe Personality Scale , 1999, Assessment.

[42]  J K Udupa,et al.  Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.

[43]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.

[44]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[45]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[46]  Joseph B. Martin.  Huntington's disease , 1984, Neurology.

[47]  M Filippi,et al.  Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis. , 2009, Progress in brain research.

[48]  Brian Patenaude,et al.  Bayesian statistical models of shape and appearance for subcortical brain segmentation , 2007 .

[49]  Stephen M. Smith,et al.  Bayesian statistical models of shape and appearance for subcortical brain segmentation , 2007 .

[50]  J. Dehmeshki,et al.  The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.

[51]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[52]  J. McGowan,et al.  The physical basis of magnetization transfer imaging. , 1999, Neurology.